Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 3
1963 1
1965 1
1970 1
1971 5
1972 1
1973 2
1974 3
1975 2
1978 2
1979 3
1981 2
1982 4
1983 3
1984 5
1985 5
1986 8
1987 10
1988 7
1989 4
1990 8
1991 5
1992 5
1993 3
1994 6
1995 6
1996 4
1997 1
1998 3
1999 2
2000 4
2001 1
2002 4
2003 4
2004 4
2005 3
2006 3
2007 7
2008 3
2009 2
2010 3
2011 4
2012 3
2013 2
2014 7
2015 6
2016 5
2017 2
2018 1
2020 2
2021 3
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

179 results

Results by year

Filters applied: . Clear all
Page 1
Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial.
Ponsioen CY, de Groof EJ, Eshuis EJ, Gardenbroek TJ, Bossuyt PMM, Hart A, Warusavitarne J, Buskens CJ, van Bodegraven AA, Brink MA, Consten ECJ, van Wagensveld BA, Rijk MCM, Crolla RMPH, Noomen CG, Houdijk APJ, Mallant RC, Boom M, Marsman WA, Stockmann HB, Mol B, de Groof AJ, Stokkers PC, D'Haens GR, Bemelman WA; LIR!C study group. Ponsioen CY, et al. Lancet Gastroenterol Hepatol. 2017 Nov;2(11):785-792. doi: 10.1016/S2468-1253(17)30248-0. Epub 2017 Aug 31. Lancet Gastroenterol Hepatol. 2017. PMID: 28838644 Clinical Trial.
Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial.
Stevens TW, Haasnoot ML, D'Haens GR, Buskens CJ, de Groof EJ, Eshuis EJ, Gardenbroek TJ, Mol B, Stokkers PCF, Bemelman WA, Ponsioen CY; LIR!C study group. Stevens TW, et al. Lancet Gastroenterol Hepatol. 2020 Oct;5(10):900-907. doi: 10.1016/S2468-1253(20)30117-5. Epub 2020 Jun 30. Lancet Gastroenterol Hepatol. 2020. PMID: 32619413 Clinical Trial.
Translational control of gene expression.
Jansen M, de Moor CH, Sussenbach JS, van den Brande JL. Jansen M, et al. Among authors: van den brande jl. Pediatr Res. 1995 Jun;37(6):681-6. doi: 10.1203/00006450-199506000-00001. Pediatr Res. 1995. PMID: 7651749 Review.
Pulmonary embolism.
Schrijvers D, Van den Brande J, Vermorken JB. Schrijvers D, et al. Among authors: van den brande j. N Engl J Med. 1998 Nov 19;339(21):1555; author reply 1557. doi: 10.1056/NEJM199811193392116. N Engl J Med. 1998. PMID: 9841332 No abstract available.
Somatomedins.
Van den Brande JL, Van Buul S. Van den Brande JL, et al. Isr J Med Sci. 1975 Jul;11(7):693-8. Isr J Med Sci. 1975. PMID: 169215 Review. No abstract available.
Somatomedins on the move.
Van den Brande JL. Van den Brande JL. Horm Res. 1990;33(2-4):58-68. doi: 10.1159/000181486. Horm Res. 1990. PMID: 1698702 Review. No abstract available.
The benefits of humanized yeast models to study Parkinson's disease.
Franssens V, Bynens T, Van den Brande J, Vandermeeren K, Verduyckt M, Winderickx J. Franssens V, et al. Among authors: van den brande j. Oxid Med Cell Longev. 2013;2013:760629. doi: 10.1155/2013/760629. Epub 2013 Jul 1. Oxid Med Cell Longev. 2013. PMID: 23936613 Free PMC article. Review.
Catch-up growth. Possible mechanisms.
Van den Brande JL. Van den Brande JL. Acta Endocrinol Suppl (Copenh). 1986;279:13-23. doi: 10.1530/acta.0.112s013. Acta Endocrinol Suppl (Copenh). 1986. PMID: 2946132 Review. No abstract available.
Diarrhea and the rationale to use Sandostatin.
Peeters M, Van den Brande J, Francque S. Peeters M, et al. Among authors: van den brande j. Acta Gastroenterol Belg. 2010 Jan-Mar;73(1):25-36. Acta Gastroenterol Belg. 2010. PMID: 20458847 Free article. Review.
Risk factors for primary sclerosing cholangitis.
Boonstra K, de Vries EM, van Geloven N, van Erpecum KJ, Spanier M, Poen AC, van Nieuwkerk CM, Witteman BJ, Tuynman HA, Naber AH, Kingma PJ, Beuers U, Ponsioen CY; Epi PSC PBC Study Group. Boonstra K, et al. Liver Int. 2016 Jan;36(1):84-91. doi: 10.1111/liv.12894. Epub 2015 Aug 28. Liver Int. 2016. PMID: 26077553
179 results